Michelle Parsons

Chief Financial Officer
Michelle joined Right2health Pharmaceuticals in August of 2019 as Chief Financial Officer. Prior to joining Right2health, Michelle served as senior vice president, financial planning & analysis for Horizon Therapuetics (HZNP), a public biopharmaceutical company. Michelle has over 20 years of experience leading corporate finance, financial reporting, business planning, and systems implementation in the pharmaceutical/medical device industry at the US and global level, including 4 years at Horizon Pharma, 7 years at Fenwal/Fresenius Kabi, and 10 years at Dade Behring.